Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Insmed receives FDA notification over Arikace in NTM treatment
The clinical holds placed on the trial were based on an initial review by FDA of the interim results of a long-term rat inhalation carcinogenicity study reported to
The clinical holds placed on the trial were based on an initial review by FDA of the interim results of a long-term rat inhalation carcinogenicity study reported to
According to the deal, BeiGene will in-license intetumumab (CNTO-95) for clinical development and commercialization within Australia, China, Hong Kong, New Zealand, Korea, Singapore and Taiwan. Intetumumab is a
The combined company will have its presence established in more than 60 countries and generated nearly $20bn revenues on a pro-forma basis for the twelve months ended June
The company is a part of the EU-funded project SEtTReND (Schistosoma Epigenetics – Targets, Regulation, New Drugs) with major focus on drug discovery, dddmag.com reported. The project involves
As per the license agreenent signed between the two companies in 2004 agreement, they will share all data and associated know-how of the MN-221 development program. MN-221 is
The lawsuit was registered for submission of an abbreviated new drug application (ANDA) to the US Food and Drug Administration’s (FDA) prior to the expiration of Noven’s patents
Humana’s experience in health care and Pfizer’s expertise in researching and developing medicines will bring together data and scientific information to better understand patient needs and the effectiveness
According to the company, it is all set to release its first set of Cannabis Science brand formulations through its producing lab and initial Colorado State licensed dispensary.
The deal comprises development of generic pharmaceutical products by Micro Labs, moneyweb.co.za reported. moneyweb.co.za quoted Litha Healthcare Group CEO Selwyn Kahanovitz saying that the agreement would help them
The companies intend to establish themselves in the fields of production, marketing and distribution of pharmaceutical products in Russia, inpharm.com reported. The UPC which is a complex of